| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Yukihiro Nagatsu CEO | TWSE Exchange | TW0004556006 ISIN |
| Japan Country | 133 Employees | - Last Dividend | - Last Split | - IPO Date |
KAINOS Laboratories, Inc., based in Tokyo, Japan, is a multifaceted company engaged in the development, manufacturing, marketing, distribution, and import/export of a wide array of products. Founded in 1975, originally operating under the name DOMS-IATRON Co., Ltd., it shifted its identity to its current name in the same year. The company’s diverse portfolio encompasses pharmaceuticals, diagnostic reagents, related chemical products, as well as physical and chemical measurement instruments, and medical supplies. Beyond healthcare and scientific markets, KAINOS Laboratories also extends its prowess into the nutrition supplements, foodstuff, animal feed, and related products sectors, establishing itself as a significant entity in both health and science sectors within Japan.
A cutting-edge liquid form creatinine measurement reagent kit compatible with a broad range of automatic analyzer systems. This product underscores KAINOS Laboratories’ capability in facilitating advanced biochemical clinical testing.
A specialized liquid form reagent kit designed for clinical applications, emphasizing the company’s focus on delivering precise diagnostic tools to the healthcare sector.
This kit stands out for its efficiency in liquid urea nitrogen measurement, showcasing KAINOS Laboratories' commitment to supporting clinical laboratories with high-quality reagents.
A two-site enzyme-linked immunosorbent assay kit tailored for the measurement of FGF-23 in serum, reflecting KAINOS Laboratories’ expertise in the niche domain of enzyme analysis.
An innovative diagnostic tool for the detection of noroviruses, enhancing KAINOS Laboratories' influence in the area of infectious disease management through rapid testing.
A reliable testing solution for identifying type A and B influenza virus antigens, contributing to the global fight against influenza through fast and efficient diagnostics.
Designed for the detection of Group A beta-hemolytic streptococci, this product signifies KAINOS Laboratories’ dedication to broadening its portfolio in point-of-care diagnostic solutions.